SEC Form 13F Information Table Summary
Business Context and Reporting Period
This filing is a Form 13F Information Table submitted to the U.S. Securities and Exchange Commission. The reporting entity is Lloyds Banking Group Plc, and the data reflects holdings as of the period ending March 31, 2015. This form discloses the equity securities held by institutional investment managers, not the operating financial results of Lloyds Banking Group itself.
Key Financial Metrics and Holdings
The filing details a portfolio of U.S. equity securities and exchange-traded funds (ETFs). The table lists the issuer, title of class, CUSIP, value (in thousands), shares/principal amount, and voting authority. Key observations include:
- Top Holdings by Value: The largest positions by reported value include Pfizer Inc ($93,714k), EMC Corp ($73,324k), Microsoft Corp ($56,530k), and Charles Schwab Corp ($40,890k).
- Portfolio Composition: The portfolio is diversified across sectors including Technology (Microsoft, Apple, Oracle), Healthcare (Pfizer, Johnson & Johnson, Aetna), Financials (Wells Fargo, JPMorgan Chase, American Express), and Energy (Chevron, Exxon Mobil).
- Voting Authority: For all listed securities, the investment manager holds Sole voting authority (Column 7), with no shared or none voting authority reported.
- Derivatives: No put or call options are reported in the "PRN AMT" or "PUT/CALL" columns for these specific line items.
Material Changes
The filing text provided is a static snapshot of holdings as of March 31, 2015. It does not provide comparative data against the prior quarter (December 31, 2014) or prior year. Therefore, material changes in position size, new acquisitions, or divestitures cannot be determined from this document alone.
Guidance, Outlook, and Risks
As a regulatory disclosure of holdings, this Form 13F does not contain management commentary, financial guidance, outlook, risk factors, or contingencies regarding Lloyds Banking Group's operations or the future performance of the underlying securities. The filing includes a standard disclaimer that the SEC has not reviewed the information for accuracy or completeness.
Investor Verification Checklist
- Verify the total aggregate value of the portfolio by summing the "VALUE" column, noting that the provided text lists individual line items but does not explicitly state the total portfolio value.
- Confirm the specific CUSIP numbers for large positions (e.g., Pfizer, Microsoft) to ensure accurate identification of share classes.
- Compare this list against the previous quarter's 13F filing (if available) to identify significant turnover or concentration changes.
- Note that the "Value" column is reported in thousands (x$1,000); ensure calculations adjust for this scale.
- Recognize that this filing reflects Lloyds Banking Group's investment portfolio, not its core banking revenue or profit metrics.